Bent Holmegaard

Urodan ApS provides equipment for monitoring of bladder condition. It is a privately-owned investment and business incubator in Denmark focused on patentable medical devices. Its bladder monitor uses patent pending 3D technology to ensure optimal permanent monitoring and ad hoc measurement of the filling of the bladder. The firm's system uses a collection of separate phased-array ultrasound transducers arranged in a circular pattern. The company was founded by Niels K. Kristiansen on July 2, 2002 and is headquartered in Rungsted Kyst, Denmark.

Chempaq was formed in 2001 by Ulrik Larsen who is the founder, based on Larsen idea to redefine the hematology test by creating a single use self contained cassette module. This PAQ (cassette) was designed to be easy to use automatically calibrated and to deliver high accuracy and precision. In February 2005, the Chempaq XBC was CE marked. Later in the same year in December, the Chempaq XBC received a 510(k) clearance from the FDA. Since 2005, Doctors offices and Hospitals have provided patients with a unique infection diagnosis using the Chempaq XBC product.

Pharma 2100 ApS engages in the research and development of pharmaceutical products. It conducts research on medical drugs to obtain patents and possible productions of these drugs. The company was founded on January 1, 2002 and is headquartered in Vanløse, Denmark.